Accordingly, a pathogenic loop between PCSK9 and inflammation (i.e., systemic inflammation induces PCSK9, which in turn promotes vascular inflammation) may be speculated, which may contribute to accelerated atherosclerosis in patients with rheumatic diseases. This evidence concerns the gene PCSK9 and atherosclerosis.